Fannin Innovation Studio Names Melissa Singh Principal
Life science commercialization company Fannin Innovation Studio (www.FanninInnovation.com) today promoted its first entrepreneur fellow, biomedical scientist Melissa Singh, Ph.D., to principal. With this move, entrepreneur fellow Erol Bakkalbasi, M.Sc. has been named senior entrepreneur... - February 17, 2016
Fannin Innovation Studio Forms Molecular Therapeutics Company Exotect, LLC.
Researchers behind Exotect LLC have honed in on a novel molecular pathway that controls the overproduction of mucus during asthma attacks. More than 25 million people suffer with asthma, a chronic disease in which airways become inflamed, swell and produce excess mucus making it difficult to breathe. - November 07, 2015
Fannin Innovation Studio’s Atul Varadhachary Appointed to Jones Health Care Advisory Board
Diverse group of industry leaders to enhance Rice University’s Health Care Initiative. - October 24, 2015
Fannin Innovation Studio Expands Team as Life Science Portfolio Grows
Dr. Michael Heffernan to lead R&D of novel biomedical technologies. - July 29, 2015
Fannin Innovation Studio and University of Houston Announce the Formation of GuidaBot, LLC
Technology enables interventions using real-time MRI guidance. - July 25, 2015
Houston Biotech Firm Closes $7.3 Million Fundraising Round
Early-stage life science commercialization company Fannin Partners, LLC announced the completion of its private offering of Class A units. Proceeds from the offering will fund the further expansion of the company’s portfolio of startups. - March 06, 2015